Mml Investors Services, LLC Horizon Therapeutics Public LTD CO Transaction History

Mml Investors Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $718,292 - $759,655	-6,693 Reduced 45.65%	7,968 $870,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $92,212 - $168,196	1,478 Added 11.21%	14,661 $1.67 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $78,127 - $112,272	1,326 Added 11.18%	13,183 $816,000
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $116,797 - $171,165	1,471 Added 14.16%	11,857 $946,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $158,407 - $201,281	1,833 Added 21.43%	10,386 $1.09 Million

Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $36,467 - $44,366	370 Added 4.52%	8,553 $922,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $19,944 - $23,950	217 Added 2.72%	8,183 $896,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $45,707 - $50,837	-530 Reduced 6.24%	7,966 $746,000
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $172,032 - $228,674	2,395 Added 39.26%	8,496 $782,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $16,080 - $20,253	-240 Reduced 3.78%	6,101 $446,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $350,213 - $506,836	6,341 New	6,341 $493,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.